TNBG ‐5602, a novel derivative of quinoxaline, inhibits liver cancer growth via upregulating peroxisome proliferator‐activated receptor γ in vitro and in vivo

ConclusionsOur results suggested that TNBG ‐5602 might exert potent anticancer activity through increasing the expression of PPARγ.

Source: Journal of Pharmacy and Pharmacology - August 24, 2019 Category: Drugs & Pharmacology Authors: Xuelian Hu, Chunmei Wan, Zongjie Gan, Rongxing Liu, Yongjie Chen, Jing Wang, Linling Gan, Yuhang Chen, Yingbo Li, Baicheng He, Yu Yu Tags: Research Paper Source Type: research